Bekelis Kimon, Missios Symeon, MacKenzie Todd A, Labropoulos Nicos, Roberts David W
Section of Neurosurgery, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA.
Department of Neurosurgery, Cleveland Clinic, Cleveland, Ohio, USA.
J Neurointerv Surg. 2016 Mar;8(3):316-22. doi: 10.1136/neurintsurg-2014-011575. Epub 2015 Jan 12.
Cost containment is the cornerstone of the Affordable Care Act. Although studies have compared the cost of cerebral aneurysm clipping (CAC) and coiling, they have not focused on identification of drivers of cost after CAC, or prediction of its magnitude. The objective of the present study was to develop and validate a predictive model of hospitalization cost after CAC.
We performed a retrospective study involving CAC patients who were registered in the Nationwide Inpatient Sample (NIS) database from 2005 to 2010. The two cohorts of ruptured and unruptured aneurysms underwent 1:1 randomization to create derivation and validation subsamples. Regression techniques were used for the creation of a parsimonious predictive model.
Of the 7798 patients undergoing CAC, 4505 (58%) presented with unruptured and 3293 (42%) with ruptured aneurysms. Median hospitalization cost was US$24,398 (IQR $17,079 to $38,249) and $73,694 (IQR $46,270 to $115,128) for the two cohorts, respectively. Common drivers of cost identified in the multivariate analyses included the following: length of stay, number of admission diagnoses and procedures, hospital size and region, and patient income. The models were validated in independent cohorts and demonstrated final R(2) values very similar to the initial models. The predicted and observed values in the validation cohort demonstrated good correlation.
This national study identified significant drivers of hospitalization cost after CAC. The presented model can be utilized as an adjunct in the cost containment debate and the creation of data driven policies.
成本控制是《平价医疗法案》的基石。尽管已有研究比较了脑动脉瘤夹闭术(CAC)和栓塞术的成本,但它们并未专注于确定CAC术后成本的驱动因素,也未对其成本规模进行预测。本研究的目的是开发并验证一种CAC术后住院成本的预测模型。
我们进行了一项回顾性研究,纳入了2005年至2010年在全国住院患者样本(NIS)数据库中登记的CAC患者。将破裂和未破裂动脉瘤的两组患者进行1:1随机分组,以创建推导和验证子样本。采用回归技术创建一个简约的预测模型。
在7798例行CAC的患者中,4505例(58%)为未破裂动脉瘤,3293例(42%)为破裂动脉瘤。两组患者的住院费用中位数分别为24,398美元(四分位间距为17,079美元至38,249美元)和73,694美元(四分位间距为46,270美元至115,128美元)。多变量分析中确定的常见成本驱动因素包括:住院时间、入院诊断和手术数量、医院规模和地区以及患者收入。这些模型在独立队列中得到验证,最终的R(2)值与初始模型非常相似。验证队列中的预测值和观察值显示出良好的相关性。
这项全国性研究确定了CAC术后住院成本的重要驱动因素。所提出的模型可作为成本控制辩论和制定数据驱动政策的辅助工具。